OxRML/AgentSLR huggingface dataset:
Parameter: Seroprevalence - IgG (Seroprevalence)
Value: 49.7 Percentage (%) ()
Exponent (base 10): 0
Uncertainty: 41.9 - 57.5 (95% CI)
Case definition: Unspecified
Numerator/denominator: 77 / 155 (method: Unspecified)
Seroprevalence adjustment: Unspecified
Statistical approach: Observed sample statistic
Disaggregated by: Age, Other, Sex, Symptoms
Trimester exposed: Unspecified
Population: General population, sex: Both, ages  to 
Country: Suriname
Location: Kwamalasamutu
Setting: Household based, Rural area
Sample size: 155
Study period: Jan 2017 - Feb 2017
Parameter: Seroprevalence - Neutralisation/PRNT (Seroprevalence)
Value: 38.2 Percentage (%) ()
Exponent (base 10): 0
Uncertainty: 33.7 - 42.9 (95% CI)
Case definition: Unspecified
Numerator/denominator: 162 / 424 (method: Unspecified)
Seroprevalence adjustment: Unspecified
Statistical approach: Observed sample statistic
Disaggregated by: Age, Other, Sex, Symptoms
Trimester exposed: Unspecified
Population: Persons under investigation, sex: Both, ages  to 
Country: Suriname
Location: Paramaribo
Setting: Hospital based, Urban area
Sample size: 424
Study period: Jan 2017 - Feb 2017
Parameter: Seroprevalence - Neutralisation/PRNT (Seroprevalence)
Value: 36.7 Percentage (%) ()
Exponent (base 10): 0
Uncertainty: 30.1 - 43.7 (95% CI)
Case definition: Unspecified
Numerator/denominator: 70 / 191 (method: Unspecified)
Seroprevalence adjustment: Unspecified
Statistical approach: Observed sample statistic
Disaggregated by: Age, Other, Sex, Symptoms
Trimester exposed: Unspecified
Population: Persons under investigation, sex: Both, ages  to 
Country: Suriname
Location: Laduani
Setting: Hospital based, Rural area
Sample size: 191
Study period: Jan 2017 - Feb 2017
Parameter: Seroprevalence - Neutralisation/PRNT (Seroprevalence)
Value: 24.5 Percentage (%) ()
Exponent (base 10): 0
Uncertainty: 18.4 - 31.9 (95% CI)
Case definition: Unspecified
Numerator/denominator: 38 / 155 (method: Unspecified)
Seroprevalence adjustment: Unspecified
Statistical approach: Observed sample statistic
Disaggregated by: Age, Other, Sex, Symptoms
Trimester exposed: Unspecified
Population: General population, sex: Both, ages  to 
Country: Suriname
Location: Kwamalasamutu
Setting: Household based, Rural area
Sample size: 155
Study period: Jan 2017 - Feb 2017
Parameter: Seroprevalence - IgM (Seroprevalence)
Exponent (base 10): 0
Numerator/denominator: 1 / 18 (method: )
Trimester exposed: Unspecified
Population: Persons under investigation, sex: Female, ages  to 
Country: United States
Location: Hawaii
Setting: Other, Unspecified
Sample size: 18
Study period: 2009 - 2012
Parameter: Seroprevalence - IgG (Seroprevalence)
Exponent (base 10): 0
Numerator/denominator: 4 / 18 (method: )
Trimester exposed: Unspecified
Population: Persons under investigation, sex: Female, ages  to 
Country: United States
Location: Hawaii
Setting: Other, Unspecified
Sample size: 18
Study period: 2009 - 2012
Parameter: Attack rate (Attack rate)
Value: 94 Percentage (%) (Median)
Exponent (base 10): 0
Statistical approach: Estimated model parameter
Reproduction number method: Compartmental model 
Population: Persons under investigation, sex: , ages  to 
Country: France
Location: French Polynesia
Setting: Population based, 
Study period: 11 Oct 2013 - 28 Mar 2014
Parameter: Reproduction number (Basic R0) (Reproduction number)
Value: 3.5 No units (Median)
Exponent (base 10): 0
Uncertainty: 2.6 - 5.3 (95% CrI)
Statistical approach: Estimated model parameter
Reproduction number method: Compartmental model Vector-human
Population: Persons under investigation, sex: , ages  to 
Country: France
Location: Tahiti, French Polynesia
Setting: Population based, 
Study period: 11 Oct 2013 - 28 Mar 2014
Parameter: Reproduction number (Basic R0) (Reproduction number)
Value: 4.1 No units (Median)
Exponent (base 10): 0
Uncertainty: 3.1 - 5.7 (95% CrI)
Statistical approach: Estimated model parameter
Reproduction number method: Compartmental model Vector-human
Population: Persons under investigation, sex: , ages  to 
Country: France
Location: Sous-le-vent Islands, French Polynesia
Setting: Population based, 
Study period: 11 Oct 2013 - 28 Mar 2014
Parameter: Reproduction number (Basic R0) (Reproduction number)
Value: 4.8 No units (Median)
Exponent (base 10): 0
Uncertainty: 3.2 - 8.4 (95% CrI)
Statistical approach: Estimated model parameter
Reproduction number method: Compartmental model Vector-human
Population: Persons under investigation, sex: , ages  to 
Country: France
Location: Mo'orea, French Polynesia
Setting: Population based, 
Study period: 11 Oct 2013 - 28 Mar 2014
Parameter: Reproduction number (Basic R0) (Reproduction number)
Value: 3 No units (Median)
Exponent (base 10): 0
Uncertainty: 2.2 - 6.1 (95% CrI)
Statistical approach: Estimated model parameter
Reproduction number method: Compartmental model Vector-human
Population: Persons under investigation, sex: , ages  to 
Country: France
Location: Tuamotu-Gambier, French Polynesia
Setting: Population based, 
Study period: 11 Oct 2013 - 28 Mar 2014
Parameter: Reproduction number (Basic R0) (Reproduction number)
Value: 2.6 No units (Median)
Exponent (base 10): 0
Uncertainty: 1.7 - 5.3 (95% CrI)
Statistical approach: Estimated model parameter
Reproduction number method: Compartmental model Vector-human
Population: Persons under investigation, sex: , ages  to 
Country: France
Location: Marquesas Islands, French Polynesia
Setting: Population based, 
Study period: 11 Oct 2013 - 28 Mar 2014
Parameter: Reproduction number (Basic R0) (Reproduction number)
Value: 3.1 No units (Median)
Exponent (base 10): 0
Uncertainty: 2.2 - 4.6 (95% CrI)
Statistical approach: Estimated model parameter
Reproduction number method: Compartmental model Vector-human
Population: Persons under investigation, sex: , ages  to 
Country: France
Location: Australes, French Polynesia
Setting: Population based, 
Study period: 11 Oct 2013 - 28 Mar 2014
Parameter: Mosquito delay - extrinsic incubation period (Mosquito)
Value: 10 Days (Median)
Exponent (base 10): 0
Uncertainty: 6.3 - 14 (95% CrI)
Statistical approach: Estimated model parameter
Population: Persons under investigation, sex: , ages  to 
Country: France
Location: French Polynesia
Setting: Population based, 
Study period: Unspecified
Parameter: Human delay - incubation period (Human delay)
Value: 6.6 Days (Median)
Exponent (base 10): 0
Uncertainty: 4.2 - 11 (95% CrI)
Statistical approach: Estimated model parameter
Population: Persons under investigation, sex: , ages  to 
Country: France
Location: French Polynesia
Setting: Population based, 
Study period: 11 Oct 2013 - 28 Mar 2014
Parameter: Human delay - infectious period (Human delay)
Value: 5.6 Days (Median)
Exponent (base 10): 0
Uncertainty: 4 - 10 (95% CrI)
Statistical approach: Estimated model parameter
Population: Persons under investigation, sex: , ages  to 
Country: France
Location: French Polynesia
Setting: Population based, 
Study period: Unspecified
Parameter: Human delay - incubation period (Human delay)
Value: 6.4 Days (Mean)
Exponent (base 10): 0
Uncertainty: 5.7 - 7 (95% CI)
Distribution: Weibull
Case definition: Clinically diagnosed/symptomatic;Confirmed
Statistical approach: Estimated model parameter
Population: Persons under investigation, sex: Both, ages 1 to 81
Country: United States
Location: All Travellers
Setting: Travel based, Unspecified
Sample size: 197
Study period: 1 Jan 2015 - 23 Jun 2016
Parameter: Human delay - incubation period (Human delay)
Value: 6 Days (Mean)
Exponent (base 10): 0
Uncertainty: 5.2 - 6.8 (95% CI)
Distribution: Weibull
Case definition: Clinically diagnosed/symptomatic;Lab confirmed
Statistical approach: Estimated model parameter
Population: Persons under investigation, sex: Both, ages  to 
Country: United States
Location: Travellers <2 weeks travel
Setting: Travel based, Unspecified
Sample size: 79
Study period: 1 Jan 2015 - 23 Jun 2016
Parameter: Seroprevalence - IgM (Seroprevalence)
Value: 6.2 Percentage (%) ()
Exponent (base 10): 0
Case definition: Lab confirmed
Numerator/denominator: 29 / 468 (method: Naive)
Seroprevalence adjustment: Naive
Statistical approach: Observed sample statistic
Disaggregated by: Sex, Symptoms
Trimester exposed: Unspecified
Population: General population, sex: Both, ages  to 
Country: Nigeria
Location: Plateau, Nasarawa
Setting: Community based, Unspecified
Sample size: 468
Study period: Jan 2016 - Dec 2016
Parameter: Seroprevalence - IgG (Seroprevalence)
Value: 3.6 Percentage (%) ()
Exponent (base 10): 0
Case definition: Lab confirmed
Numerator/denominator: 17 / 468 (method: Naive)
Seroprevalence adjustment: Naive
Statistical approach: Observed sample statistic
Disaggregated by: Sex, Symptoms
Trimester exposed: Unspecified
Population: General population, sex: Both, ages  to 
Country: Nigeria
Location: Plateau, Nasarawa
Setting: Community based, Unspecified
Sample size: 468
Study period: Jan 2016 - Dec 2016
Parameter: Seroprevalence - IgG and IgM (Seroprevalence)
Exponent (base 10): 0
Case definition: Lab confirmed
Numerator/denominator: 54 / 214 (method: Unspecified)
Seroprevalence adjustment: Unspecified
Trimester exposed: Unspecified
Population: Pregnant women, sex: Female, ages  to 
Country: Brazil
Location: Rio de Janeiro
Setting: Hospital based, Urban area
Sample size: 219
Study period: Jan 2015 - Aug 2016
Parameter: Reproduction number (Basic R0) (Reproduction number)
Value: 6 No units (Mean)
Exponent (base 10): 0
Uncertainty: 0.06 - 11.95 (95% CI)
Statistical approach: Estimated model parameter
Disaggregated by: Region
Reproduction number method: Other Other
Country: France
Location: French Polynesia
Study period: 2013 - 2014
Parameter: Seroprevalence - Neutralisation/PRNT (Seroprevalence)
Value: 62.1 Percentage (%) (Unspecified)
Exponent (base 10): 0
Numerator/denominator: 74 / 119 (method: )
Seroprevalence adjustment: Naive
Statistical approach: Observed sample statistic
Population: General population, sex: Both, ages 4 to 80
Country: Mexico
Location: Chiapas State
Setting: Population based, Unspecified
Sample size: 119
Study period: 30 Nov 2015 - 18 Dec 2015
Parameter: Reproduction number (Effective; Re) - Sexual (Reproduction number)
Value: 3.3 No units (Unspecified)
Exponent (base 10): 0
Uncertainty: 1.3 - 5.3 (95% CI)
Statistical approach: Estimated model parameter
Reproduction number method: Growth rate Unspecified
Population: Children, sex: Unspecified, ages  to 
Country: Nicaragua
Location: Managua
Setting: Community based, Urban area
Study period: Jun 2016
Parameter: Reproduction number (Effective; Re) - Sexual (Reproduction number)
Value: 3.4 No units (Unspecified)
Exponent (base 10): 0
Uncertainty: 2.4 - 4.7 (95% CI)
Statistical approach: Estimated model parameter
Reproduction number method: Growth rate Unspecified
Population: Children, sex: Unspecified, ages  to 
Country: Nicaragua
Location: Managua
Setting: Community based, Urban area
Study period: Jun 2016 - Jul 2016
Parameter: Growth rate (r) (Growth rate)
Value: 0.2 Unspecified (Unspecified)
Exponent (base 10): 0
Uncertainty: 0.1 - 0.4 (95% CI)
Statistical approach: Estimated model parameter
Population: Children, sex: Unspecified, ages  to 
Country: Nicaragua
Location: Managua
Setting: Community based, Urban area
Study period: Jun 2016 - Jul 2016
Parameter: Growth rate (r) (Growth rate)
Value: 0.1 Unspecified (Unspecified)
Exponent (base 10): 0
Uncertainty: 0.1 - 0.2 (95% CI)
Statistical approach: Estimated model parameter
Population: Children, sex: Unspecified, ages  to 
Country: Nicaragua
Location: Managua
Setting: Community based, Urban area
Study period: Jun 2016 - Jul 2016
Parameter: Reproduction number (Basic R0) (Reproduction number)
Value: 2.055 No units (Median)
Exponent (base 10): 0
Uncertainty: 0.523 - 6.3 (95% CI)
Statistical approach: Estimated model parameter
Reproduction number method: Compartmental model Other
Population: General population, sex: Unspecified, ages  to 
Country: Multi-country: Brazil, Colombia, El Salvador
Setting: Population based, Unspecified
Study period: Apr 2015 - 27 Feb 2016
Parameter: Reproduction number (Basic R0) - Vector-borne (Reproduction number)
Value: 1.96 No units (Median)
Exponent (base 10): 0
Uncertainty: 0.45 - 6.227 (95% CI)
Statistical approach: Estimated model parameter
Reproduction number method: Compartmental model Vector-human
Population: General population, sex: Unspecified, ages  to 
Country: Multi-country: Brazil, Colombia, El Salvador
Setting: Population based, 
Study period: Apr 2015 - 27 Feb 2016
Parameter: Reproduction number (Basic R0) - Sexual (Reproduction number)
Value: 0.136 No units (Median)
Exponent (base 10): 0
Uncertainty: 0.009 - 0.521 (95% CI)
Statistical approach: Estimated model parameter
Reproduction number method: Compartmental model Human-human
Population: General population, sex: Unspecified, ages  to 
Country: Multi-country: Brazil, Colombia, El Salvador
Setting: Population based, 
Study period: Apr 2015 - 27 Feb 2016
Parameter: Reproduction number (Basic R0) (Reproduction number)
Value: 1.79 No units (Unspecified)
Exponent (base 10): 0
Uncertainty: 1.68 - 1.91 (Other)
Reproduction number method: Other Other
Population: General population, sex: Unspecified, ages  to 
Country: France
Location: Yap Island, French Polynesia
Setting: Population based, Unspecified
Study period: 2007
Parameter: Seroprevalence - Neutralisation/PRNT (Seroprevalence)
Value: 2 Percentage (%) (Unspecified)
Exponent (base 10): 0
Case definition: Lab confirmed
Numerator/denominator: 3 / 150 (method: )
Seroprevalence adjustment: Adjusted
Statistical approach: Observed sample statistic
Population: Blood donors, sex: Unspecified, ages  to 
Country: Cameroon
Location: Maroua
Setting: Other, 
Sample size: 150
Study period: Aug 2015 - Oct 2015
Parameter: Seroprevalence - Neutralisation/PRNT (Seroprevalence)
Value: 4.8 Percentage (%) (Unspecified)
Exponent (base 10): 0
Case definition: Lab confirmed
Numerator/denominator: 9 / 186 (method: )
Seroprevalence adjustment: Adjusted
Statistical approach: Observed sample statistic
Population: Blood donors, sex: Unspecified, ages  to 
Country: Cameroon
Location: Garoua
Setting: Other, 
Sample size: 186
Study period: Aug 2015 - Oct 2015
Parameter: Seroprevalence - Neutralisation/PRNT (Seroprevalence)
Value: 2  (Unspecified)
Exponent (base 10): 0
Case definition: Lab confirmed
Numerator/denominator: 3 / 149 (method: )
Seroprevalence adjustment: Adjusted
Statistical approach: Observed sample statistic
Population: Blood donors, sex: Unspecified, ages  to 
Country: Cameroon
Location: Ngaoundere
Setting: Other, 
Sample size: 149
Study period: Aug 2015 - Oct 2015
Parameter: Seroprevalence - Neutralisation/PRNT (Seroprevalence)
Value: 10  (Unspecified)
Exponent (base 10): 0
Case definition: Lab confirmed
Numerator/denominator: 17 / 170 (method: )
Seroprevalence adjustment: Adjusted
Statistical approach: Observed sample statistic
Population: Blood donors, sex: Unspecified, ages  to 
Country: Cameroon
Location: Douala
Setting: Other, 
Sample size: 170
Study period: Aug 2015 - Oct 2015
Parameter: Seroprevalence - Neutralisation/PRNT (Seroprevalence)
Value: 3.3  (Unspecified)
Exponent (base 10): 0
Case definition: Lab confirmed
Numerator/denominator: 9 / 272 (method: )
Seroprevalence adjustment: Adjusted
Statistical approach: Observed sample statistic
Population: Blood donors, sex: Unspecified, ages  to 
Country: Cameroon
Location: Yaounde
Setting: Other, 
Sample size: 272
Study period: Aug 2015 - Oct 2015
Parameter: Seroprevalence - Neutralisation/PRNT (Seroprevalence)
Value: 7.6  (Unspecified)
Exponent (base 10): 0
Case definition: Lab confirmed
Numerator/denominator: 12 / 157 (method: )
Seroprevalence adjustment: Adjusted
Statistical approach: Observed sample statistic
Population: Blood donors, sex: Unspecified, ages  to 
Country: Cameroon
Location: Bertoua
Setting: Other, 
Sample size: 157
Study period: Aug 2015 - Oct 2015
Parameter: Reproduction number (Basic R0) - Sexual (Reproduction number)
Value: 7.6 No units (Median)
Exponent (base 10): 0
Uncertainty: 4.8 - 14 (95% CI)
Statistical approach: Estimated model parameter
Disaggregated by: Method
Reproduction number method: Next generation matrix Vector-human
Population: Persons under investigation, sex: , ages  to 
Country: Federated States of Micronesia
Location: Yap Main Islands
Setting: Population based, Rural
Sample size: 108
Study period: Apr 2007 - Jul 2007
Parameter: Severity - proportion of symptomatic cases (Severity)
Value: 23.2 Percentage (%) (Mean)
Exponent (base 10): 0
Case definition: Lab confirmed
Numerator/denominator: 133 / 573 (method: )
Population: Pregnant women, sex: Female, ages  to 
Country: France
Location: French Guiana
Setting: Population based, 
Sample size: 573
Study period: 1 Feb 2016 - 1 Jun 2016
Parameter: Reproduction number (Basic R0) (Reproduction number)
Value:  No units (Mean)
Exponent (base 10): 0
Bounds: 1.29 - 1.71
Statistical approach: Estimated model parameter
Disaggregated by: Method
Reproduction number method: Branching process Unspecified
Trimester exposed: Unspecified
Population: Persons under investigation, sex: Unspecified, ages  to 
Country: Brazil
Location: Centre-West Brazil
Setting: Population based, Unspecified
Sample size: 44825
Study period: 1 Jan 2015 - 19 Nov 2016
Parameter: Reproduction number (Basic R0) (Reproduction number)
Value:  No units (Mean)
Exponent (base 10): 0
Bounds: 1.58 - 2.48
Statistical approach: Estimated model parameter
Disaggregated by: Method
Reproduction number method: Branching process Unspecified
Trimester exposed: Unspecified
Population: Persons under investigation, sex: Unspecified, ages  to 
Country: Brazil
Location: North Brazil
Setting: Population based, Unspecified
Sample size: 22373
Study period: 1 Jan 2015 - 19 Nov 2016
Parameter: Reproduction number (Basic R0) (Reproduction number)
Value:  No units (Mean)
Exponent (base 10): 0
Bounds: 1.75 - 3.12
Statistical approach: Estimated model parameter
Disaggregated by: Method, Time
Reproduction number method: Branching process Unspecified
Trimester exposed: Unspecified
Population: Persons under investigation, sex: Unspecified, ages  to 
Country: Brazil
Location: Northeast Brazil
Setting: Population based, Unspecified
Sample size: 122779
Study period: 1 Jan 2015 - 19 Nov 2016
Parameter: Reproduction number (Basic R0) (Reproduction number)
Value:  No units (Mean)
Exponent (base 10): 0
Bounds: 1.98 - 3.85
Statistical approach: Estimated model parameter
Disaggregated by: Method
Reproduction number method: Branching process Unspecified
Trimester exposed: Unspecified
Population: Persons under investigation, sex: Unspecified, ages  to 
Country: Brazil
Location: South-East Brazil
Setting: Population based, Unspecified
Sample size: 112689
Study period: 1 Jan 2015 - 19 Nov 2016
Parameter: Reproduction number (Basic R0) (Reproduction number)
Value:  No units (Mean)
Exponent (base 10): 0
Bounds: 1.61 - 2.57
Statistical approach: Estimated model parameter
Disaggregated by: Method
Reproduction number method: Branching process Unspecified
Trimester exposed: Unspecified
Population: Persons under investigation, sex: Unspecified, ages  to 
Country: Brazil
Location: South Brazil
Setting: Population based, Unspecified
Sample size: 4944
Study period: 1 Jan 2015 - 19 Nov 2016
Parameter: Mutations - evolutionary rate (Mutations)
Value: 1.12 Substitutions/site/year (Unspecified)
Exponent (base 10): -3
Uncertainty: 0.97 - 1.27 (95% CrI)
Statistical approach: Estimated model parameter
Genome site: Whole genome sequence
Genomic lineage: Asian; AmZIKV lineage
Trimester exposed: Unspecified
Population: Persons under investigation, sex: Unspecified, ages  to 
Country: Multi-country: Americas, Asia, Oceania
Setting: Unspecified, Unspecified
Sample size: 254
Study period: 1966 - 1 Mar 2016
Parameter: Mutations - evolutionary rate (Mutations)
Value:  Substitutions/site/year (Mean)
Exponent (base 10): -3
Bounds: 0.98 - 1.06
Statistical approach: Estimated model parameter
Disaggregated by: Method
Genome site: near-complete genome
Genomic lineage: Asian lineage
Population: , sex: Unspecified, ages  to 
Country: Multi-country: Africa (n = 4), Americas (n = 9), Asia (n = 7), Oceania (n = 4), Europe (n = 2)
Study period: 1947 - Dec 2015
Parameter: Mutations - evolutionary rate (Mutations)
Value: 1.2 Substitutions/site/year (Mean)
Exponent (base 10): -3
Uncertainty: 0.951 - 1.41 (HPDI 95%)
Statistical approach: Estimated model parameter
Genome site: Whole genome sequence
Population: Unspecified, sex: Unspecified, ages  to 
Country: Multi-country: South and Central America (n = 8), Asia (n = 5), Oceania (n = 1)
Location: Martinique
Setting: Unspecified, Unspecified
Sample size: 39
Study period: 2007 - 2016
Parameter: Attack rate (Attack rate)
Value: 78 Percentage (%) (Central)
Exponent (base 10): 0
Uncertainty: 63.5 - 86.3 (95% CI)
Statistical approach: Estimated model parameter
Disaggregated by: Region
Population: General population, sex: Unspecified, ages  to 
Country: France
Location: French Polynesia
Setting: Population based, Unspecified
Study period: Aug 2013 - May 2014
Parameter: Attack rate (Attack rate)
Value: 20.8 Percentage (%) (Central)
Exponent (base 10): 0
Uncertainty: 1.1 - 50.3 (95% CI)
Statistical approach: Estimated model parameter
Population: General population, sex: Unspecified, ages  to 
Country: Colombia
Setting: Population based, Unspecified
Study period: Aug 2015 - May 2016
Parameter: Attack rate (Attack rate)
Value: 32.4 Percentage (%) (Central)
Exponent (base 10): 0
Uncertainty: 2.5 - 94.2 (95% CI)
Statistical approach: Estimated model parameter
Population: General population, sex: Unspecified, ages  to 
Country: Brazil
Location: Bahia
Setting: Population based, Unspecified
Study period: Feb 2015 - Feb 2016
Parameter: Attack rate (Attack rate)
Value: 71.3 Percentage (%) (Central)
Exponent (base 10): 0
Uncertainty: 67.4 - 94.1 (95% CI)
Statistical approach: Estimated model parameter
Population: General population, sex: Unspecified, ages  to 
Country: France
Location: Tahiti, French Polynesia
Setting: Population based, Unspecified
Study period: Aug 2013 - May 2014
Parameter: Attack rate (Attack rate)
Value: 70.1 Percentage (%) (Central)
Exponent (base 10): 0
Uncertainty: 66.3 - 92.5 (95% CI)
Statistical approach: Estimated model parameter
Population: General population, sex: Unspecified, ages  to 
Country: France
Location: Sous-le-vent Islands, French Polynesia
Setting: Population based, Unspecified
Study period: Aug 2013 - May 2014
Parameter: Attack rate (Attack rate)
Value: 62.5 Percentage (%) (Unspecified)
Exponent (base 10): 0
Uncertainty: 59.2 - 82.5 (95% CI)
Population: General population, sex: Unspecified, ages  to 
Country: France
Location: "Other four archipelagos", French Polynesia
Setting: Population based, Unspecified
Study period: Aug 2013 - May 2014
Parameter: Reproduction number (Basic R0) - Sexual (Reproduction number)
Value:  No units (Central)
Exponent (base 10): 0
Bounds: 0.5 - 2.5
Statistical approach: Unspecified
Reproduction number method: Unspecified Vector-human
Population: General population, sex: Unspecified, ages  to 
Country: Multi-country: Brazil, Colombia, French Polynesia
Setting: Population based, Unspecified
Study period: Aug 2013 - Jun 2016
Parameter: Attack rate (Attack rate)
Value: 14.6 Per 10,000 population (Unspecified)
Exponent (base 10): 0
Bounds: 3.6 - 21.5
Case definition: Confirmed;Probable
Numerator/denominator: 108 / 7391 (method: )
Statistical approach: Observed sample statistic
Disaggregated by: Age, Region, Sex
Population: Persons under investigation, sex: Both, ages  to 
Country: Federated States of Micronesia
Location: Yap Island
Setting: Hospital based, 
Sample size: 185
Study period: 1 Apr 2007 - 31 Jul 2007
Parameter: Seroprevalence - IgM (Seroprevalence)
Value: 74 Percentage (%) (Unspecified)
Exponent (base 10): 0
Case definition: Lab confirmed
Numerator/denominator: 414 / 557 (method: )
Seroprevalence adjustment: Naive
Statistical approach: Observed sample statistic
Disaggregated by: Sex
Trimester exposed: Unspecified
Population: General population, sex: Both, ages 3 to 
Country: Federated States of Micronesia
Location: Yap Island
Setting: Household based, Unspecified
Sample size: 557
Study period: 1 Apr 2007 - 31 Jul 2007